Meckley, Lisa; Gudgeon, James; Anderson, Jeffrey; … - In: PharmacoEconomics 28 (2010) 1, pp. 61-74
<Emphasis Type="Bold">Background: In 2007, the US FDA added information about pharmacogenomics to the warfarin label based on the influence of the CYP2C9 and VKORC1 genes on anticoagulation-related outcomes. Payers will be facing increasing demand for coverage decisions regarding this technology, but the potential...</emphasis>